Precision diagnostics: moving towards protein biomarker signatures of clinical utility in cancer
- PMID: 28154374
- DOI: 10.1038/nrc.2016.153
Precision diagnostics: moving towards protein biomarker signatures of clinical utility in cancer
Abstract
Interest in precision diagnostics has been fuelled by the concept that early detection of cancer would benefit patients; that is, if detected early, more tumours should be resectable and treatment more efficacious. Serum contains massive amounts of potentially diagnostic information, and affinity proteomics has risen as an accurate approach to decipher this, to generate actionable information that should result in more precise and evidence-based options to manage cancer. To achieve this, we need to move from single to multiplex biomarkers, a so-called signature, that can provide significantly increased diagnostic accuracy. This Opinion article focuses on the progress being made in identifying protein biomarker signatures of clinical utility, using blood-based proteomics.
Similar articles
-
Recent advances in salivary cancer diagnostics enabled by biosensors and bioelectronics.Biosens Bioelectron. 2016 Jul 15;81:181-197. doi: 10.1016/j.bios.2016.02.040. Epub 2016 Feb 18. Biosens Bioelectron. 2016. PMID: 26946257 Review.
-
Cancer Proteomics and the Elusive Diagnostic Biomarkers.Proteomics. 2019 Nov;19(21-22):e1800445. doi: 10.1002/pmic.201800445. Epub 2019 Aug 7. Proteomics. 2019. PMID: 31172665
-
Circulating tumor DNA as a liquid biopsy _target for detection of pancreatic cancer.World J Gastroenterol. 2016 Oct 14;22(38):8480-8488. doi: 10.3748/wjg.v22.i38.8480. World J Gastroenterol. 2016. PMID: 27784960 Free PMC article. Review.
-
Proteomics in cancer research: Are we ready for clinical practice?Crit Rev Oncol Hematol. 2015 Dec;96(3):437-48. doi: 10.1016/j.critrevonc.2015.07.006. Epub 2015 Aug 12. Crit Rev Oncol Hematol. 2015. PMID: 26277237 Review.
-
Serum proteomics in biomedical research: a systematic review.Appl Biochem Biotechnol. 2013 Jun;170(4):774-86. doi: 10.1007/s12010-013-0238-7. Epub 2013 Apr 23. Appl Biochem Biotechnol. 2013. PMID: 23609910 Review.
Cited by
-
Interfacial interactions of SERS-active noble metal nanostructures with functional ligands for diagnostic analysis of protein cancer markers.Mikrochim Acta. 2021 Apr 12;188(5):164. doi: 10.1007/s00604-021-04807-z. Mikrochim Acta. 2021. PMID: 33844071 Review.
-
Lipid and protein tumor markers for head and neck squamous cell carcinoma identified by imaging mass spectrometry.Onco_target. 2020 Jul 14;11(28):2702-2717. doi: 10.18632/onco_target.27649. eCollection 2020 Jul 14. Onco_target. 2020. PMID: 32733643 Free PMC article.
-
CMBD: a manually curated cancer metabolic biomarker knowledge database.Database (Oxford). 2021 Mar 9;2021:baaa094. doi: 10.1093/database/baaa094. Database (Oxford). 2021. PMID: 33693668 Free PMC article.
-
Identifying heterogeneous subgroups of systemic autoimmune diseases by applying a joint dimension reduction and clustering approach to immunomarkers.BioData Min. 2024 Sep 16;17(1):36. doi: 10.1186/s13040-024-00389-7. BioData Min. 2024. PMID: 39285420 Free PMC article.
-
A Toolbox for Functional Analysis and the Systematic Identification of Diagnostic and Prognostic Gene Expression Signatures Combining Meta-Analysis and Machine Learning.Cancers (Basel). 2019 Oct 21;11(10):1606. doi: 10.3390/cancers11101606. Cancers (Basel). 2019. PMID: 31640282 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources